Loading...
Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials
BACKGROUND: Due to the short half-life of levodopa, immediate-release carbidopa-levodopa (IR CD-LD) produces fluctuating LD concentrations, contributing to a risk of eventual motor complications. IPX066 was designed to rapidly attain therapeutic LD concentrations and maintain them to allow a dosing...
Saved in:
| Published in: | J Parkinsons Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
IOS Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927929/ https://ncbi.nlm.nih.gov/pubmed/26444090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-150622 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|